Novel active substance launches, five-year total (excluding COVID-19 products)
Cumulative number of novel active substances launched over a five-year period, excluding COVID-19 vaccines and therapeutics.
Unit Count Industry Healthcare
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Novel active substance launches, five-year total (excluding COVID-19 products)
Global, 2021–2025
Every record
All records
2 records · 1 region · 2021–2025
Primary documents
Sources
2 documents. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Global R&D Trends 2026 | IQVIA | — | 1 |
| Global R&D Trends 2026 | IQVIA | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Novel active substance launches, five-year total (excluding COVID-19 products). Retrieved from https://statorigin.org/indicators/novel-active-substance-launches-five-year-total-excluding-covid-19-products